HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer.

Abstract
The product of the dek oncogene is the 43-kDa DEK nuclear protein. DEK was first identified in a fusion with the CAN nucleoporin protein in a specific subtype of acute myelogenous leukemia. DEK has also been shown to be an autoantigen in patients with pauciarticular onset juvenile rheumatoid arthritis. Further, the last 65 amino acids of DEK can partially reverse the mutation-prone phenotype of cells from patients with ataxia-telangiectasia. However, in spite of these significant disease associations, the function of DEK has remained unclear. The HIV-2 peri-ets (pets) site is a TG-rich element found between the two Elf-1 binding sites in the HIV-2 enhancer. The pets element mediates transcriptional activation whether the enhancer is stimulated by phorbol 12-myristate 13-acetate (PMA) alone, phytohemagluttinin (PHA) alone, PMA plus PHA, soluble antibodies to the T cell receptor, immobilized antibodies to the T cell receptor, or by antigen. Previously, we purified and characterized the pets factor, demonstrating that it is a 43-kDa nuclear protein. We now describe the identification of DEK as this 43-kDa pets factor. Using a modified Southwestern screening procedure, we find that DEK can recognize the pets element. We demonstrate the ability of recombinant DEK to bind specifically to the pets site using the electrophoretic mobility shift assay (EMSA) and DNase I footprinting. "Supershift" EMSA further confirms that DEK is the dominant protein binding to the pets site in T cell extracts. Our findings show that DEK is a site-specific DNA binding protein that is likely involved in transcriptional regulation and signal transduction. This has implications for multiple pathogenic processes, including hematologic malignancies, arthritis, ataxia-telangiectasia, and AIDS caused by HIV-2.
AuthorsG K Fu, G Grosveld, D M Markovitz
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 94 Issue 5 Pg. 1811-5 (Mar 04 1997) ISSN: 0027-8424 [Print] United States
PMID9050861 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Autoantigens
  • Chromosomal Proteins, Non-Histone
  • DNA Probes
  • DNA-Binding Proteins
  • Dek protein, human
  • Nuclear Proteins
  • Oncogene Proteins
  • Poly-ADP-Ribose Binding Proteins
  • Recombinant Fusion Proteins
  • Deoxyribonuclease I
Topics
  • Autoantigens (metabolism)
  • Chromosomal Proteins, Non-Histone
  • Cloning, Molecular
  • DNA Probes
  • DNA-Binding Proteins (metabolism)
  • Deoxyribonuclease I (metabolism)
  • HIV Enhancer
  • HIV-2 (genetics)
  • Humans
  • Jurkat Cells
  • Leukemia, Myeloid, Acute (genetics)
  • Nuclear Proteins (chemistry, metabolism)
  • Oncogene Proteins (metabolism)
  • Poly-ADP-Ribose Binding Proteins
  • Recombinant Fusion Proteins (metabolism)
  • Signal Transduction
  • T-Lymphocytes (chemistry, metabolism)
  • Transcription, Genetic
  • Translocation, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: